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GRAPHICAL ABSTRACT 
 
 
 
 
 
 
 
 
 
Fluoxetine hydrochloride 
(fluorinated antidepressant) 
4 primary aromatics 
1 chloroaromatic 
4 carboxylic acids 
CO2 
F 
NO3
 UVA light 
BDD(OH) OH 
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Research Highlights 
 
 Fluoxetine hydrochloride treated with Pt, RuO2-based or BDD anode and H2O2 generation 
 Faster mineralization by PEF with a BDD anode due to BDD(OH), OH and UVA light 
 Pseudo-first-order decay by AO-H2O2, EF and, more rapidly, by PEF using a BDD anode 
 Degradation of fluoxetine with F and NO3

 formation and partial Cl

 oxidation to HClO 
 Detection of 4 primary aromatics, 1 chloroaromatic derivative and 4 carboxylic acids 
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Abstract 
The degradation of the fluorinated antidepressant fluoxetine, as hydrochloride, was comparatively 
studied in sulfate medium at pH 3.0 by anodic oxidation with electrogenerated H2O2 (AO-H2O2), 
electro-Fenton (EF) and photoelectro-Fenton (PEF). Experiments were performed with 100 mL 
solutions in an undivided tank reactor equipped with a Pt, RuO2-based or boron-doped diamond 
(BDD) anode and an air-diffusion cathode for continuous H2O2 production. The BDD anode 
showed higher mineralization rate due to the great production of physisorbed BDD(

OH), which has 
larger reactivity to oxidize the drug and intermediates. The degradation rate was enhanced by EF 
with 0.50 mM Fe
2+
 due to the additional production of 

OH in the bulk from Fenton’s reaction. The 
degradation was even faster using PEF owing to the additional photolytic action of UVA radiation. 
The most effective process was PEF with a BDD anode achieving 94% mineralization at 300 min. 
The fluoxetine decay followed a pseudo-first-order kinetics, being quicker in the order: AO-H2O2 < 
EF < PEF. The effect of the current density and drug concentration on the mineralization rate and 
fluoxetine decay was clarified. Oxidation of fluoxetine by hydroxyl radicals yielded four aromatic 
by-products, as found by GC-MS. Additionally, a chloroaromatic compound was identified as a 
result of the reaction of active chlorine, which was formed in situ from the oxidation of chloride ion 
at the BDD anode. Four short-chain linear carboxylic acids, being oxalic and formic acid more 
abundant, were identified. In PEF, fluorine atoms of fluoxetine were completely released as fluoride 
ion, whereas the initial nitrogen was converted to nitrate ion in all cases. A reaction pathway for 
fluoxetine mineralization by the electrochemical advanced methods is finally proposed. 
 
Keywords: Anodic oxidation with electrogenerated H2O2; Electro-Fenton; Fluoxetine; Oxidation 
products; Photoelectro-Fenton 
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1. Introduction 
 Fluoxetine (see physicochemical characteristics in Table 1), also known by the trade names, 
Prozac, Sarafem or Fontex, is a fluorinated antidepressant belonging to the selective serotonin 
reuptake inhibitor (SSRI) class [1]. It is prescribed for the treatment of a number of mental 
disorders, such as depressive disorder, obsessive-compulsive disorder, bulimia nervosa, panic 
disorder and premenstrual dysphoric disorder. It is cited within the World Health Organization's 
List of Essential Medicines and considered as an important medication for a basic health system. 
The large production and prescription of fluoxetine in the entire world has caused its emerging 
occurrence in the aquatic environment, mainly in rivers at ng L
-1
 levels [2]. The presence of 
fluoxetine in the environment is due to its direct disposal from households, the excretion of 
unmetabolized drug and through pharmaceutical wastes. Its inefficient removal by common 
physicochemical and biological methods used in wastewater treatments plants (WWTPs) is a matter 
of concern [3,4]. Fluoxetine concentrations up to 0.01 g L-1 have been determined in WWTP 
effluents and up to 4.7 mg (kg of organic carbon)
-1
 has been found in sludges [1]. Furthermore, it 
has also been detected in drinking water at very low concentrations [1,5], which verifies the 
inefficiency of conventional treatments. Despite the low concentration of fluoxetine in the aquatic 
environment, several studies have revealed its bioaccumulation in fish tissues (from 0.14 to 1.02 g 
kg
-1
) [6,7] and its toxicity over algae and small invertebrates [8-11]. In particular, this drug interacts 
with growth and reproduction processes in invertebrates [9]. This suggests that fluoxetine can exert 
potential noxious effects on living beings. Hence, new treatments for removing this pollutant and its 
metabolites from wastewater need to be devised. Recently, different methods such as sonolysis [12], 
advanced oxidation processes (AOPs) including O3/H2O2 [13,14], TiO2 photocatalysis in the 
presence of O3 and H2O2 [13], and H2O2/UV [15] have been reported within this framework. To the 
best of our knowledge, the degradation of fluoxetine using electrochemical AOPs (EAOPs) has not 
been yet reported in the literature. 
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 Over the last 15 years, there has been an increasing interest in developing EAOPs based on in 
situ H2O2 production such as anodic oxidation with electrogenerated H2O2 (AO-H2O2), electro-
Fenton (EF) and photoelectro-Fenton (PEF) [3,16-19]. These treatments involve the production of 
reactive oxygen species (ROS) on site, including H2O2 via two-electron reduction of O2 gas 
(reaction (1)) at carbonaceous cathodes like BDD [20,21], activated carbon or graphite felt [22-25], 
carbon sponge [26], carbon nanotubes [27,28] and carbon-polytetrafluoroethylene (PTFE) gas 
diffusion devices [16,17,29,30]. 
O2(g)  +  2 H
+
  +  2 e

    H2O2        (1) 
 In AO-H2O2 using an undivided electrolytic cell, dissolved organics can be oxidized by (i) 
direct charge transfer at the anode (M), (ii) reaction with physic/chemisorbed hydroxyl radical 
M(

OH) originated from anodic water discharge, and (iii) reaction with H2O2 and its oxidation 
products like adsorbed hydroperoxyl radical M(HO2

) produced at the anode as follows [3,18]: 
M   +  H2O2    M(HO2

)  +  H
+
  +  e

       (2)  
 The 

OH radical is the second strongest oxidizing species known after fluorine. The high 
standard reduction potential of this radical (Eº(OH/H2O) = 2.80 V/SCE) explains its large ability to 
react with most of the organics, thus mineralizing them to carbon dioxide, water and inorganic ions 
[18,19]. The preferred anode in AO-H2O2 is the BDD thin-layer electrode due to its remarkable 
stability in acidic and alkaline conditions, low adsorption of organics and 

OH, and larger O2-
evolution overvoltage as compared with conventional anodes like Pt and PbO2 [31-34]. Due to these 
properties, great amounts of reactive BDD(

OH) are produced at the BDD anode from reaction (3), 
which enhances the degradation of organics [35,36]. 
BDD  +  H2O    BDD(

OH)  +  H
+
  +  e

       (3)  
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 In EF, the oxidation ability of electrogenerated H2O2 is upgraded by addition of Fe
2+
, since it 
generates homogeneous 

OH and Fe
3+
 ion via Fenton’s reaction (4) at optimum pH ~ 3 [3,4,37]. 
Organics are mainly oxidized by both, adsorbed M(

OH) and homogeneous 

OH. The effectiveness 
of reaction (4) is assured by its propagation from the cathodic reduction of Fe
3+
 to Fe
2+
 [22,34]. 
However, the degradation of aromatic compounds in EF is inhibited due to the formation of stable 
complexes between Fe(III) and short carboxylic acids [29,30]. To overcome this problem, UVA 
photoassisted PEF process, in which the solution is irradiated with artificial UVA light, has been 
successfully applied [29,38-41]. This radiation facilitates the mineralization of organics because the 
Fe
2+
 regeneration and 

OH production in the bulk are enhanced upon photoreduction of Fe(OH)
2+
 
species by reaction (5) and photolysis of Fe(III)-carboxylate complexes by reaction (6). 
Fe
2+
  +  H2O2    Fe
3+
  +  

OH  +  OH

       (4) 
Fe(OH)
2+
  +  h    Fe2+  +   OH          (5) 
Fe(OOCR)
2+
  +  h    Fe2+  +  CO2  + R

       (6) 
 Lately, we have been interested in assessing the performance of EAOPs for the removal of 
organic pollutants (pesticides, dyes and pharmaceuticals) from wastewater in order to show their 
viability at larger scale. However, the scale-up is limited by the high cost of the BDD anode, thus 
being necessary to test the oxidation ability of these methods with much less expensive anode 
materials such as RuO2-based ones, routinely used in chloride media [3]. For this reason, we have 
undertaken a study on the abatement of fluoxetine by AO-H2O2, EF and PEF using Pt, RuO2-based 
and BDD anodes. The classical Pt anode was chosen to clearly analyze the degradation power of the 
cheaper RuO2-based one, being both of them considered as low oxidation power anodes. 
 This paper reports the degradation behavior of fluoxetine by using its commercial form, i.e., 
hydrochloride salt. In order to clarify the oxidation pathways and compare the oxidation power of 
these processes with Pt, RuO2-based and BDD as anodes, higher drug contents as compared to those 
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found in the environment were used. The influence of current density (j) and drug content on the 
mineralization rate and drug decay was examined. The time course of fluoxetine concentration and 
the evolution of by-products such as inorganic ions, short-chain aliphatic acids and aromatic 
compounds were determined by chromatographic techniques. From these results, a plausible 
reaction pathway for fluoxetine mineralization by means of the EAOPs has been finally proposed. 
2. Experimental 
2.1. Chemicals 
 Fluoxetine hydrochloride (99% purity) was purchased from Fluka (St. Louis, MO, USA) and 
used as received. Maleic, fumaric, oxalic and formic acids were of analytical grade supplied by 
Sigma-Aldrich (St. Louis, MO, USA) and Panreac (Barcelona, Spain). Sodium sulfate and 
heptahydrated iron(II) sulfate were of analytical grade supplied by Fluka and Sigma-Aldrich, 
respectively. Ultrapure water from a Millipore Milli-Q system (Billerica, MA, USA) with resistivity 
> 18 M cm at 25 ºC was utilized to prepare all the solutions. The initial pH of solutions was 
adjusted to 3.0 with analytical grade sulfuric acid supplied by Merck (Darmstadt, Germany). Other 
chemicals were either of HPLC or analytical grade purchased from Merck and Panreac. 
2.2. Instruments 
 The pH values of solutions were determined with a Crison GLP 22 pH-meter (Barcelona, 
Spain). Total organic carbon (TOC) was measured with a Shimadzu VCSN TOC analyzer (Kyoto, 
Japan), which was coupled with a Shimadzu TNM-1 unit to obtain the total nitrogen (TN) in the 
solution. Reproducibility of TOC measurements was 1%. Electrochemical assays were performed 
at constant j with an Amel 2053 potentiostat-galvanostat (Milano, Italy). The stability of the 
electrolytic system was monitored from the continuous measurement of the potential difference of 
the cell by using a Demestres 601BR digital multimeter (Barcelona, Spain). High-performance 
liquid chromatography (HPLC) measurements were carried out with a Waters 600 LC (Cerdanyola 
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del Vallès, Spain) coupled with a Waters 996 photodiode array detector. For reversed-phase HPLC, 
the LC was fitted with a Waters Spherisorb ODS2-C18 5µm, 150 mm  4.6 mm (i.d.), column at 25 
ºC and the detector was set at  = 227 nm for quantification of fluoxetine. For ion-exclusion HPLC, 
a Bio-Rad Aminex HPX 87H, 300 mm  7.8 mm (i.d.), column at 35 ºC was used, and the detector 
was set at  = 210 nm for quantification of carboxylic acids. Inorganic anions were quantified by 
ion chromatography. F

 and Cl

 concentrations were determined using a Shimadzu 10 Avp LC 
fitted with a Shim-Pack IC-A1S, 100 mm × 4.6 mm (i.d.), anion column at 40 ºC coupled with a 
Shimadzu CDD 10 Avp conductivity detector. NO3
−
 concentration was measured with a Kontron 
465 LC (Bonaduz, GR, Switzerland) equipped with the above column at 35 ºC and coupled with a 
Waters 432 conductivity detector and a Kontron 332 UV/Vis detector set at  = 214 nm. The NH4
+ 
content was determined with an Alpkem Flow Solution IV flow injection system (Hood River, OR, 
USA) through colorimetric analysis based on the standard indophenol blue reaction. Gas 
chromatography-mass spectrometry (GC-MS) analysis was made with an Agilent Technologies 
6890N GC (Tokyo, Japan) fitted with a non-polar Teknokroma Sapiens-X5ms 0.25 µm, 30 m × 
0.25 mm (i.d.), column and coupled with a 5975C MS operating in EI mode at 70 eV. 
2.3. Electrolytic system 
 Fluoxetine hydrochloride solutions were electrolyzed using an undivided, open glass tank 
reactor of 150 mL with a double jacket for circulation of thermostated water at 35 ºC, under 
vigorous stirring at 800 rpm provided by a magnetic PTFE follower. The anode was either a Pt 
sheet of 99.99% purity supplied by SEMPSA (Barcelona, Spain), a DSA-Cl2 (RuO2-based anode) 
plate purchased from NMT Electrodes (Pinetown, South Africa) or a BDD thin-film electrode 
supplied by NeoCoat (La-Chaux-de-Fonds, Switzerland). The cathode was a carbon-PTFE air-
diffusion electrode (ADE) provided by E-TEK (Somerset, NJ, USA), mounted as described 
elsewhere [17] and fed with air pumped at 1 L min
-1
 for continuous H2O2 generation. The geometric 
area of all the electrodes was 3 cm
2
 and the interelectrode gap was kept at about 1 cm. In PEF trials, 
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the solution was irradiated with a 6-W Philips black light blue tube lamp placed 7 cm above its 
surface. The lamp emitted in the  range of 320-400 nm (max = 360 nm) and supplied 5 W m
-2
, as 
detected with a Kipp&Zonen CUV 5 UV radiometer (Delft, The Netherlands). Before use, the BDD 
anode and ADE cathode were polarized in 0.050 M Na2SO4 at j = 100 mA cm
-2
 for 180 min to 
remove the impurities from the anode surface and to activate the cathode. 
2.4. Analytical methods 
 For TOC measurements, all the samples withdrawn from solutions were filtered with 0.45 µm 
PTFE membrane filters from Whatman (Madrid, Spain). From these data, the mineralization current 
efficiency (MCE) at a given current I (in A) and electrolysis time t (in h) was calculated from 
equation (7) [42]: 
% MCE =                                        100       (7) 
where F is the Faraday constant (96,487 C mol
-1
), Vs is the solution volume (in L), (TOC)exp is 
the solution TOC abatement (in mg L
-1
), 4.32  107 is a conversion factor to homogenize units 
(3,600 s h
-1
  12,000 mg C mol-1) and m = 17 is the number of carbon atoms of fluoxetine. The 
number n of electrons needed for the theoretical total mineralization of the protonated form of the 
drug was taken as 86 from equation (8), considering the formation of CO2 and F

 and NO3

 ions, as 
will be discussed below. 
C17H19F3NO
+
  +  36 H2O    17 CO2  +  3 F

   +  NO3

  +  91 H
+
  +  86 e

  (8) 
 During the EF and PEF treatments, a small volume of acetonitrile was added to the samples 
collected before chromatographic analysis in order to stop the degradation of fluoxetine and its by-
products. All the HPLC and ion chromatography measurements were made by injecting 20-25 µL 
aliquots into the LC systems. The mobile phase for reversed-phase HPLC was a 50% (v/v) 
acetonitrile/water (10 mM KH2PO4, pH 3.0) mixture at 1 mL min
-1
 and chromatograms displayed a 
n F Vs (TOC)exp 
   4.32107 m I t 
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peak for fluoxetine at retention time (tr) of 12.3 min. For ion-exclusion HPLC, the mobile phase 
was 4 mM H2SO4 at 0.6 mL min
-1
 and chromatograms exhibited peaks related to oxalic acid (tr = 
6.8 min), maleic acid (tr = 8.1 min), formic acid (tr = 13.7 min) and fumaric acid (tr = 15.2 min). For 
F

 and Cl

 determination, a solution with 2.4 mM tris(hydroxymethyl)aminomethane and 2.5 mM 
phthalic acid at pH 4.0 was eluted at 1.5 mL min
-1
 as mobile phase, whereas for determining NO3

, 
the mobile phase was prepared with boric acid, sodium gluconate, sodium tetraborate, acetonitrile, 
butanol and glycerine, being eluted at 2.0 mL min
-1
. 
 TOC and kinetic measurements under each experimental condition were done in triplicate with 
good reproducibility and average values are given throughout the text. In figures, error bars related 
to the 95% confidence interval of each average data are also depicted. 
 The stable aromatic by-products formed during the electrolysis of 100 mL of a 0.490 mM 
fluoxetine hydrochloride solution after 15, 120 and 240 min of AO-H2O2 at j = 100 mA cm
-2
 were 
analyzed by GC-MS using a NIST05-MS library for identification. After each electrolysis, the 
organic components were extracted out with CH2Cl2 (3  15 mL) and the organic volume was 
reduced to ca. 1 mL after drying over anhydrous Na2SO4 followed by filtration. The temperature 
program for GC-MS analysis was 36 ºC for 1 min, 5 ºC min
-1
 up to 320 ºC and hold time 10 min. 
The temperature of the inlet, source and transfer line was 250, 230 and 300 ºC, respectively. 
3. Results and discussion 
3.1. Degradation of fluoxetine by AO-H2O2 with different anodes 
 To check the oxidation ability of adsorbed M(

OH) and generated H2O2 as well as of weaker 
ROS like HO2

 produced in AO-H2O2 from reactions (1)-(3), 100 mL of solutions containing 0.490 
mM fluoxetine hydrochloride and 0.050 M Na2SO4 as background electrolyte at pH 3.0 were 
comparatively treated by this EAOP using either Pt, RuO2-based or BDD as the anode at j = 100 
mA cm
-2
 for 360 min. The solution pH did not change significantly over a time. However, at the 
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end of the process, pH was slightly more acidic (pH  2.7-2.8), which is probably due to the 
formation of products like aliphatic carboxylic acids [3,18,41]. 
 Fig. 1a depicts the time course of normalized TOC for the three trials. TOC content was 
reduced by 18% and 32% after 360 min using Pt and RuO2 anodes, which indicates the poor 
mineralization ability of these electrodes. This observation implies that Pt(

OH) and, to a lesser 
extent, H2O2 have low ability to oxidize fluoxetine and its degradation intermediates. The higher 
oxidation power of the RuO2 anode can then be accounted for by a greater activity of physisorbed 
hydroxyl radical. In contrast, BDD anode exhibits 77% TOC abatement after 360 min, which agrees 
with its larger oxidation ability. The physisorbed nature of BDD(

OH), along with their formation at 
larger anodic potentials, entails a much higher oxidation efficiency for the AO-H2O2 treatment of 
fluoxetine. 
 Since j determines the quantity of oxidizing species in AO-H2O2, the effect of this operation 
parameter on the mineralization of the above 0.490 mM fluoxetine hydrochloride solution was 
examined in the range 33.3-150 mA cm
-2
 using the BDD anode. As can be seen in Fig. 1b, an 
increase in j caused a quicker TOC decay, reaching final abatements of 51%, 66%, 77% and 87% 
for growing j values. This behavior can be simply associated with the increasing generation rate of 
reactive BDD(

OH) according to reaction (3). Nevertheless, the percentage of TOC removed was 
not proportional to the applied j, which suggests the occurrence of parasitic reactions that 
diminished the oxidation ability of the process. This behavior can be confirmed from the 
corresponding MCE values calculated from Eq. (7) and presented in Fig. 1c. The current efficiency 
underwent a gradual decay with increasing j, attaining final values of 9.6%, 6.2%, 4.3% and 3.6%, 
respectively, after 360 min. This decay in MCE is typical of EAOPs and can be explained by the 
acceleration of parasitic reactions of BDD(

OH), thus being less available to oxidize organic 
molecules. The most important among those reactions is the oxidation of BDD(

OH) to O2 gas via 
reaction (9) [35,36]. Moreover, the dimerization of this radical leads to H2O2 by reaction (10), 
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which can in turn react with the radical by reaction (11) [3,18,34,38]. The production of other 
weaker oxidants at the BDD anode like the peroxodisulfate ion (S2O8
2
) from the oxidation of SO4
2
 
via reaction (12) and ozone via reaction (13) can also reduce the BDD(

OH) content and hence, the 
oxidation power of the AO-H2O2 process [18,35,36]. 
2 BDD(

OH)  2 BDD + O2(g) + 2 H
+
 + 2 e

      (9) 
2 BDD(

OH)  2 BDD + H2O2        (10) 
H2O2 + BDD(

OH)  BDD(HO2

) + H2O       (11) 
2 SO4
2
  S2O8
2
 + 2 e

         (12) 
3 H2O  O3(g) + 6 H
+
 + 6 e

         (13) 
 The progressive reduction of MCE at long time observed in all curves of Fig. 1c is also 
noticeable. This tendency can be associated with the gradual loss of organic load along with the 
production of more refractory by-products [18,36]. 
3.2. EF and PEF treatment of fluoxetine with different anodes 
 The EF process of the above 0.490 mM fluoxetine hydrochloride solution at pH 3.0 was studied 
with a BDD anode at 100 mA cm
-2
 by adding either 0.50 or 1.00 mM Fe
2+
 as catalyst of Fenton’s 
reaction (4). Fig. 2a shows a fast TOC decay for both assays, obtaining 86% and 91% TOC 
reduction, respectively. The quicker mineralization for 1.00 mM Fe
2+
 can be explained by the 
greater generation of 
OH in the bulk from the concomitant acceleration of Fenton’s reaction (4). 
Comparing with the AO-H2O2 process, the superiority of both EF assays is explained by the 
production of 

OH in the bulk, which acts in concomitance with physisorbed BDD(

OH). For 
example, after 120 min of electrolysis, TOC was reduced by 42% in AO-H2O2 (see Fig. 1a) and to a 
much larger extent of 53% and 70% for EF with 0.50 and 1.00 mM Fe
2+
, respectively (see Fig. 2a). 
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 Analogous PEF trials were comparatively performed employing a 6 W UVA lamp to irradiate 
the solutions. Fig. 2a depicts a similar mineralization rate at both Fe
2+
 concentrations, at least from 
120 min, reaching 93% of TOC reduction at 360 min. PEF performed better than EF due to the 
synergistic action of BDD(

OH), 

OH and UVA radiation over fluoxetine and its by-products. It is 
noteworthy that UVA light caused a 90% of TOC decay in only 180 min, which is greater than 70% 
achieved in EF process with 1.00 mM Fe
2+ 
(see Fig. 2a). 
 All the aforementioned findings indicate that BDD is the best anode and the oxidation power of 
the EAOPs increased in the sequence: AO-H2O2 < EF < PEF. Since similar mineralization rates 
were found for the PEF treatment with 0.50 and 1.00 mM Fe
2+
, the former content was chosen for 
addressing the effect of different experimental variables like j, anode material and drug 
concentration on the performance of this EAOP, as will be discussed below. 
 Fig. 2a shows the progressive rise in TOC abatement when j increased from 33.3 to 100 mA 
cm
-2
 for the PEF degradation of 0.490 mM fluoxetine hydrochloride solutions with 0.50 mM Fe
2+
. 
This trend can be ascribed to the greater production rate of BDD(

OH) and H2O2 due to the 
acceleration of reactions (3) and (1), respectively, along with the subsequent higher generation rate 
of 
OH from Fenton’s reaction (4), thereby yielding larger amounts of photoactive species that 
tended to be more rapidly degraded upon exposure to UVA irradiation. Nevertheless, similar TOC 
removals of 90%, 92% and 93% were finally obtained at 33.3, 66.6 and 100 mA cm
-2
, respectively. 
 The inset panel of Fig. 2a depicts a drop in MCE for the above trials as j was increased. Apart 
from reactions (9)-(13) that mainly cause a loss of BDD(

OH), other parasitic reactions can lead to a 
fall of 

OH content in the bulk. These include its dimerization by reaction (14) and its destruction 
by Fe
2+
 and H2O2 via reactions (15) and (16), respectively [3,18,38-42]. Maximum current 
efficiencies of 35.6% at 33.3 mA cm
-2
, 26.0% at 66.7 mA cm
-2
 and 20.3% at 100 mA cm
-2
 were 
obtained, finally decaying to 17.0%, 8.7% and 5.8%. The drop of MCE over time can be again 
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related to the loss of organic matter and the production of more stable molecules that are hardly 
destroyed by BDD(

OH), 

OH and UVA light, thus impeding the total mineralization by PEF. 
2 

OH  H2O2         (14) 
Fe
2+
 + 

OH  Fe3+ + OH        (15) 
H2O2 + 

OH  HO2

 + H2O        (16) 
 Fig. 2b illustrates the comparative normalized TOC abatement for a 0.490 mM fluoxetine 
hydrochloride solution with 0.50 mM Fe
2+
 treated by PEF using either a Pt, RuO2-based or BDD 
anode at j = 100 mA cm
-2
. Compared with the analogous curves for AO-H2O2 (without Fe
2+
) of Fig. 
1a, the PEF processes exhibited higher mineralization. The influence of the anode was very relevant 
again, which suggests a significant influence of the adsorbed M(

OH) on the degradation process. 
Fig. 2b shows that the mineralization rate increased in the order: RuO2-based  Pt << BDD. While 
for the two former anodes about 80% of TOC was removed after 360 min of electrolysis, a higher 
TOC reduction of 93% TOC was achieved with BDD. Taking into account the poor mineralization 
achieved with Pt and RuO2-based anodes in AO-H2O2 (see Fig. 1a), it can be inferred that 

OH and 
UVA radiation were the main oxidants in PEF with those anodes. In contrast, the quicker and larger 
mineralization attained with BDD suggests a more significant role of physisorbed BDD(

OH) for 
oxidizing the by-products, decisively contributing to the action of 

OH and UVA light. 
 The effect of initial drug concentration on the performance of PEF process with a BDD anode 
was studied using 0.50 mM Fe
2+
 at 100 mA cm
-2
. Fig. 3 corroborates the large effectiveness of this 
EAOP for removing the TOC from all the solutions, reaching > 88% of mineralization. Although 
progressively better percentages of TOC removal (up to 94%) were obtained in the 0.245-0.835 mM 
range, further diminishing, an increasing amount of TOC was always abated at higher drug 
concentrations, thereby upgrading the efficiency of the process. This behavior is shown in the inset 
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panel of Fig. 3, where the MCE values for the above trials are presented. For example, after 60 min 
of electrolysis, the current efficiency raised gradually, attaining 11.0%, 20.0%, 26.0% and 29.8% 
for increasing drug contents. Since the same quantity of BDD(

OH) and 

OH is expected to be 
accumulated at a constant j in the BDD/ADE cell, the greater efficiency results from the 
deceleration of parasitic reactions (9)-(16). This explanation is supported by the continuous drop in 
MCE with prolonging electrolysis, as can be seen for all the assays in the inset panel of Fig. 3, 
partly resulting from the gradually lower organic load. 
 From these results, it can be concluded that the best EAOP, namely PEF with a BDD anode, 
becomes more efficient at low j values and high drug concentrations, i.e., when parasitic reactions 
are strongly decelerated. This favors the reaction of organics with BDD(

OH) and 

OH, yielding 
higher amounts of photoactive intermediates that can be quickly removed under UVA irradiation. 
Despite this, 93-94% TOC reduction was reached as maximum, therefore remaining a small 
proportion of highly persistent by-products in solution. 
3.3. Decay kinetics of fluoxetine by EAOPs with a BDD anode  
 The kinetics for the removal of 0.490 mM fluoxetine under AO-H2O2, EF and PEF conditions 
using a BDD/ADE tank reactor at j = 100 mA cm
-2
 was followed by reversed-phase HPLC. A blank 
experiment demostrated that the solution remained stable upon UVA irradiation in the absence of 
current (data not shown). This informs about the photostability of the drug, being BDD(

OH) and/or 

OH the main oxidizing species generated in all the EAOPs tested. 
 Fig. 4 highlights the total removal of fluoxetine in all the treatments, needing decreasing times 
of 220 min in AO-H2O2, 120 min in EF and 50 min in PEF. This trend agrees with the relative 
oxidation power stated above for these EAOPs and confirms the low oxidation power of BDD(

OH) 
in AO-H2O2 and the much quicker action of 

OH in the bulk in EF as well as in PEF, where its 
formation is largely induced by the photolytic reaction (5). Fig. 4 shows a good agreement with a 
pseudo-first-order reaction and the excellent linear correlations can be seen in the inset panel. The 
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apparent rate constants (k1), i.e., the slopes of such straight lines, were 3.1  10
-4
 s
-1
 (R
2
 = 0.995) in 
AO-H2O2, 5.7  10
-4
 s
-1
 (R
2
 = 0.996) in EF and 1.10  10-3 s-1 (R2 = 0.987) in PEF. These results 
suggest that fluoxetine reacts with a low and constant amount of BDD(

OH) and/or 

OH in all cases 
as a result of the very short lifetime of the reactive radicals [18]. 
 The influence of j and drug concentration on fluoxetine degradation kinetics was also assessed. 
As can be seen in Fig. 5a, an increase in j caused a faster removal of the drug for a 0.420 mM 
solution under PEF conditions with a BDD anode. Total disappearance was achieved after 100, 80 
and 50 min at 33.3, 66.7 and 100 mA cm
-2
, respectively. This occurs owing to the larger generation 
of BDD(

OH) and 

OH with increasing j, as explained above. The inset panel of Fig. 5a depicts the 
straight lines obtained for these trials considering a pseudo-first-order reaction, yielding a k1 value 
of 5.6  10-4 s-1 (R2 = 0.994) at 33.3 mA cm-2, 8.1  10-4 s-1 (R2 = 0.990) at 66.7 mA cm-2 and 1.10  
10
-3
 s
-1
 (R
2
 = 0.987) at 100 mA cm
-2
. These data reveal a two-fold enhancement of k1 upon a three-
fold increase of j (from 33.3 to 100 mA cm
-2
), which confirms the concomitant loss of BDD(

OH) 
and 

OH due to the acceleration of parasitic reactions (9)-(16). On the other hand, Fig. 5b shows the 
good performance of the PEF process with a BDD anode for complete removal of fluoxetine, 
requiring between 20 and 180 min at starting contents ranging from 0.263 to 0.925 mM. The inset 
panel of Fig. 5b shows the linear correlations found for a pseudo-first-order decay in all these trials, 
yielding decreasing k1 values of 2.42  10
-3
 s
-1
 (R
2
 = 0.992), 1.10  10-3 s-1 (R2 = 0.987), 6.8  10-4 s-
1
 (R
2
 = 0.993) and 3.8  10-4 s-1 (R2 = 0.995) as the drug content rises. This behavior corroborates 
the complexity of the fluoxetine removal since it does not follow a real pseudo-first-order kinetics, 
whose intrinsic characteristic should be the absence of drug concentration effect on k1. It can be 
deduced that, at each fluoxetine content, different steady-state concentrations of BDD(

OH) and 

OH are achieved, being highly dependent on their reaction with by-products and the extent of 
parasitic reactions. 
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3.4. Product identification: Aromatics, carboxylic acids and inorganic ions 
 Table 2 summarizes the characteristics of four aromatic by-products formed directly from 
fluoxetine (1) degradation and detected by GC-MS during the AO-H2O2 treatment of a 0.490 mM 
fluoxetine hydrochloride solution at pH 3.0 and 100 mA cm
-2
. The aromatics identified were 4-
trifluoromethylphenol (2), styrene (3), its derivative benzaldehyde (4) and a product arising from 
internal cyclization, 1-methyl-3,4-dihydro-2H-quinoline (5). Moreover, one chloroaromatic 
derivative like 4-chlorophenyl benzoate (6) was detected as well. This species may result from the 
attack of active chlorine (Cl2/HClO) formed from the oxidation of Cl

 ion, which is present in the 
hydrochloride salt, at the BDD anode [43,44]. Note that the same intermediates are expected in EF 
and PEF because of the generation of the same kinds of oxidizing species in all the EAOPs. 
 Ion-exclusion chromatograms of the same solution, degraded by different treatments using a 
BDD/ADE cell at j = 100 mA cm
-2
, exhibited peaks associated to four final carboxylic acids, 
namely maleic (7), fumaric (8), oxalic (9) and formic (10). Under the conditions used in EF and 
PEF, most of these acids exist in solution in the form of Fe(III) complexes [18,24,34]. 
 Fig. 6a-c illustrates the evolution of detected carboxylic acids in AO-H2O2, EF and PEF. 
Maleic and fumaric acid, formed from the cleavage of the benzene ring of aromatic by-products 
[3,18,29], were found in concentrations below 0.4 mg L
-1
 in all cases, being at trace level in EF and 
completely disappearing at electrolysis times  360 min. This is indicative of a very rapid removal 
of both Fe(III)-maleate and Fe(III)-fumarate complexes by BDD(

OH) and 

OH. In contrast, oxalic 
acid and pre-eminently formic acid, formed from the oxidation of the two former acids and 
converted to CO2 [38-42], were accumulated to a much larger extent. Maximum contents of 3.1 
(300 min), 5.3 (240 min) and 6.5 (120 min) mg L
-1
 of oxalic acid were determined in AO-H2O2, EF 
and PEF, respectively, which dropped to 1.6, 2.6 and 0.1 mg L
-1
 after 360 min of electrolysis. This 
means that Fe(III)-oxalate species are oxidized by BDD(

OH) and photolyzed by UVA light, as 
established in previous work [24,34,38-42]. Similarly, formic acid attained 18.2 (240 min), 18.8 
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(240 min) and 22.8 (180 min) mg L
-1
 as maximal for such processes, decreasing up to a final value 
of 6.7 mg L
-1
 in AO-H2O2 and disappearing completely in EF and more quickly in PEF. Therefore, 
Fe(III)-formate complexes are oxidized by BDD(

OH) and 

OH, and can also be photodecomposed 
by UVA radiation. Considering these results and the resulting mass balance, it can be stated that the 
remaining carboxylic acids contribute in 2.1, 0.7 and < 0.1 mg L
-1
 of TOC to the final solutions 
obtained by AO-H2O2, EF and PEF, which are negligible values compared to the corresponding 23, 
14 and 7 mg L
-1
 of TOC (see Fig. 1b, 2a and 2b). Hence, EAOPs generate unidentified by-products 
that are more persistent than short-chain linear carboxylic acids to degradation by 

OH and UVA 
light. 
 The time course of inorganic ions detected during the above processes was also assessed. Fig. 
7a highlights the continuous release of F (1.470 mM, 27.93 mg L
-1
 in the solution) as F

 ion, as 
considered in reaction (8), meaning that organofluorinated by-products were slowly but gradually 
destroyed. At the end of AO-H2O2, EF and PEF degradation at j = 100 mA cm
-2
, F

 content 
accounted for 70.2%, 86.7% and 100% of initial F after 360 min, respectively. This agrees with the 
relative oxidation power of these treatments and confirms the total destruction of all fluorinated 
intermediates only under the synergistic action of BDD(

OH), 

OH and UVA light in the powerful 
PEF. This result highlights the positive action of the radiation to decontaminate the fluoxetine 
hydrochloride solution. On the other hand, Fig. 7b reveals the continuous disappearance of Cl

 ion 
(0.490 mM, 17.30 mg L
-1
 in the hydrochloride solution), reaching 80-86% removal after 360 min of 
all trials. It is well known that this ion can be oxidized to chlorine on BDD by reaction (17), being 
subsequently hydrolyzed to hypochlorous acid by reaction (18) [36,39,43,44]. The generated active 
chlorine mixture (Cl2/HClO) possesses a strong oxidizing ability at pH 3.0, which can explain the 
formation of chloroderivative 6. 
2 Cl

    Cl2(aq)  +  2 e

         (17) 
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Cl2(aq)  +  H2O    HClO  +  Cl

  +  H
+
       (18) 
 The fate of the initial N (0.490 mM, 6.86 mg L
-1
 in the solution) for the above assays was 
finally investigated. NO3

 ions were always detected in the electrolyzed solutions, as written in the 
total mineralization equation (8), but neither NO2

 nor NH4
+
 ions were found. Fig. 8a shows the 
continuous accumulation of N-NO3

 up to 1.81 mg L
-1
 in AO-H2O2, 3.84 mg L
-1
 in EF and 2.03 mg 
L
-1
 in PEF after 360 min, corresponding to 26.3%, 56.0% and 29.6% of initial N. The TN content of 
all the solutions underwent a progressive drop over time, as can be seen in Fig. 8b. It was reduced 
by 13.0%, 43.8% and 47.4% in AO-H2O2, EF and PEF, respectively. The loss of TN mainly 
suggests the release of volatile nitrogen compounds, like N2 and NxOy, as also reported for other N-
aromatics [38-42]. Note that the final solutions of AO-H2O2 and PEF contained refractory 
nitrogenated by-products, probably aliphatic derivatives, but in the case of EF, only NO3

 ions were 
present in the medium. This means that the 

OH radicals formed in the bulk in the EF process are 
able to destroy all nitrogenated by-products, whereas the action of UVA light in PEF promotes the 
formation of quite persistent nitrogenated by-products (17.8% of initial N) that become 
accumulated in the final treated solution. 
3.5. Proposed reaction sequence for fluoxetine mineralization 
 Based on the identified products, Fig. 9 presents a plausible reaction sequence for fluoxetine 
mineralization by EAOPs with a BDD anode. The main oxidants are the physisorbed BDD(

OH) 
and/or 

OH, although the degradation with active chlorine is also feasible, as stated above. In EF 
and PEF, final carboxylic acids are predominantly in the form of Fe(III) complexes, which has been 
only remarked for oxalic and formic acids for the sake of simplicity. 
 The degradation of the parent molecule 1 occurs via four parallel paths. The cleavage of one of 
the C-O bonds with simultaneous hydroxylation yields the fluorinated compound 2. The rest of the 
fluoxetine molecule is then either transformed into compound 3 with loss of its lateral amino chain, 
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followed by oxidation to compound 4, or undergo an internal cyclization via the amino group to 
yield the quinoline 5. The chlorinated compound 6 can be formed from the loss of the lateral amino 
chain by oxidation with 

OH, in concomitance with chlorination of the benzoate moiety in C4 
position with release of the trifluoromethyl group. The gradual degradation of these aromatics and 
their intermediates leads to the generation of F

 and NO3

 ions, along with the production of short-
chain linear aliphatic acids 7-10. Acids 7 and 8 are oxidized to acids 9 and 10, which are slowly 
destroyed by BDD(

OH) in AO-H2O2, whereas their Fe(III) complexes can be removed by 

OH in 
EF or photolyzed by UVA light in PEF with regeneration of Fe
2+
 (see reaction (6)). 
4. Conclusions 
 The use of a BDD anode in the AO-H2O2, EF and PEF treatment of acidic fluoxetine 
hydrochloride solutions in sulfate medium yielded a much larger mineralization than that obtained 
with Pt and RuO2-based ones, which emphasizes the great oxidation power of physisorbed 
BDD(

OH). The synergistic action of 

OH in the bulk in EF enhanced the degradation process, 
being further upgraded by the photolytic action of UVA light in PEF. The latter process with a BDD 
anode was then the most effective one, leading to 94% of TOC reduction as maximal. Current 
efficiency rose at lower j and higher drug content. The fluoxetine decays obeyed a pseudo-first-
order reaction, becoming faster in the order: AO-H2O2 < EF < PEF. The apparent rate constant 
increased with increasing j and with decreasing initial drug concentration. Four primary aromatic 
by-products coming from cleavage, hydroxylation, oxidation and internal cyclization steps, as well 
as one chloroaromatic derivative resulting from the action of active chlorine, were identified. Ion-
exclusion HPLC allowed the identification of large quantities of oxalic and formic acids. They were 
slowly destroyed by BDD(

OH) in AO-H2O2, but their Fe(III) complexes were rapidly photolyzed 
by UVA light in PEF. F atoms were completely released as F

 ion only in PEF, where the initial N 
was partially mineralized as NO3

 ion with a significant loss of volatile compounds. 
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Figure captions 
Fig. 1. Normalized TOC decay vs. electrolysis time for the degradation of 100 mL of a 0.490 mM 
fluoxetine hydrochloride solution in 0.050 M Na2SO4 at pH 3.0 and 35 ºC by anodic oxidation with 
electrogenerated H2O2 (AO-H2O2) using a stirred tank reactor equipped with an air-diffusion 
cathode (ADE) and electrodes of 3 cm
2
 area. (a) Anode: () Pt, () RuO2-based and () BDD at 
current density of 100 mA cm
-2
. (b) BDD anode, current density: () 33.3 mA cm-2, () 66.7 mA 
cm
-2
, () 100 mA cm-2 and () 150 mA cm-2. (c) Variation of mineralization current efficiency 
with electrolysis time for the above assays. 
Fig. 2. Change of normalized TOC removal with electrolysis time for the treatment of 100 mL of a 
0.490 mM fluoxetine hydrochloride solution in 0.050 M Na2SO4 at pH 3.0 and 35 ºC by electro-
Fenton (EF) and photoelectro-Fenton (PEF) using the same cell of Fig. 1. (a) BDD anode; EF with 
() 0.50 and () 1.00 mM Fe2+ at current density of 100 mA cm-2; PEF with 0.50 mM Fe2+ at 
current density: () 33.3 mA cm-2, () 66.7 mA cm-2 and () 100 mA cm-2; () PEF with 1.00 
mM Fe
2+
 at current density of 100 mA cm
-2
. The inset panel presents the corresponding variation of 
mineralization current efficiency. (b) PEF with 0.50 mM Fe
2+
 at current density of 100 mA cm
-2
. 
Anode: () Pt, () RuO2-based and () BDD. 
Fig. 3. Effect of drug concentration on TOC abatement vs. electrolysis time for the degradation of 
100 mL of fluoxetine hydrochloride solutions in 0.050 M Na2SO4 with 0.50 mM Fe
2+
 at pH 3.0 and 
35 ºC by PEF using a BDD/ADE tank reactor at current density of 100 mA cm
-2
. Fluoxetine 
hydrochloride content: () 0.245 mM, () 0.490 mM, () 0.835 mM and () 1.225 mM. The 
corresponding mineralization current efficiency is depicted in the inset panel. 
Fig. 4. Fluoxetine concentration decay for the treatment of 100 mL of 0.490 mM drug solutions in 
0.050 M Na2SO4 at pH 3.0 and 35 ºC with a BDD/ADE tank reactor at current density of 100 mA 
+ 
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cm
-2
. () AO-H2O2, () EF with 0.50 mM Fe
2+
 and () PEF with 0.50 mM Fe2+. The inset panel 
shows the kinetic analysis assuming a pseudo-first-order reaction for fluoxetine. 
Fig. 5. Time course of fluoxetine concentration for the PEF degradation of 100 mL of drug 
solutions in 0.050 M Na2SO4 with 0.50 mM Fe
2+
 at pH 3.0 and 35 ºC using a BDD/ADE cell. (a) 
0.420 mM fluoxetine hydrochloride, current density: () 33.3 mA cm-2, () 66.7 mA cm-2 and 
() 100 mA cm-2. (b) Fluoxetine hydrochloride concentration: () 0.263 mM, () 0.420 mM, () 
0.647 mM and () 0.925 mM at current density of 100 mA cm-2. The kinetic analysis for a pseudo-
first-order reaction is presented in the inset panels. 
Fig. 6. Evolution of the concentration of: () maleic (7), () fumaric (8), () oxalic (9) and () 
formic (10) acids detected during the treatment of 100 mL of a 0.490 mM fluoxetine hydrochloride 
solution in 0.050 M Na2SO4 at pH 3.0 and 35 ºC using a BDD/ADE tank reactor at current density 
of 100 mA cm
-2
. (a) AO-H2O2, (b) EF with 0.50 mM Fe
2+
 and (c) PEF with 0.50 mM Fe
2+
. 
Fig. 7. Time-course of the concentration of (a) fluoride and (b) chloride ions during the () AO-
H2O2, () EF with 0.50 mM Fe
2+
 and () PEF with 0.50 mM Fe2+, under the conditions of Fig. 6. 
Fig. 8. Evolution of (a) N-NO3

 and (b) total nitrogen during the () AO-H2O2, () EF with 0.50 
mM Fe
2+
 and () PEF with 0.50 mM Fe2+ processes under the conditions of Fig. 6. 
Fig. 9. Proposed reaction sequence for the mineralization of fluoxetine by EAOPs using a BDD 
anode. 
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Table 1 
Physicochemical characteristics of fluoxetine. 
 
IUPAC name N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine 
Molecular structure 
O
H
N
F
F
F
 
Empirical formula C17H18F3NO 
Molar mass 309.33 g mol
-1
 
Melting point 179 to 182 ºC 
Boiling point 395 ºC 
Solubility in water 14 g L
-1
 (at 20 ºC) 
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Table 2 
Organic intermediates detected by GC-MS during the AO-H2O2 treatment of 100 mL of a 0.49 mM 
fluoxetine hydrochloride solution in 0.050 M Na2SO4 at pH 3.0 and 35 ºC using a BDD/ADE cell at 
100 mA cm
-2
. 
 
 
Number 
 
Compound 
 
Molecular structure 
tr 
a
 
(min) 
Main fragmentation 
ions (m/z) 
1 Fluoxetine O
H
N
F
F
F
 
33.3 309, 44 
2 4-Trifluoromethylphenol OH
F F
F  
13.1 162, 143, 112 
3 Styrene 
 
7.4 104, 78, 51 
4 Benzaldehyde O
 
9.6 106,77 
5 1-Methyl-3,4-dihydro-
2H-quinoline 
N
 
20.6 147, 132, 118 
    
 - 30 - 
6 4-Chlorophenyl benzoate 
O
O
Cl  
27.7 232, 105 
a
 Retention time 
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Fig. 2 
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Fig. 3 
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Fig. 4 
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Fig. 5 
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Fig. 6 
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Fig. 7 
0
5
10
15
20
0 60 120 180 240 300 360 420
[C
l
] 
/ 
m
g
 L
-1
Time / min
0
5
10
15
20
25
30
35
[F

] 
/ 
m
g
 L
-1
Total fluoride
b 
a 
    
 - 38 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 
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